Search

everythinglearnresearchcommunity

for

Search:↓

LTBP1 is a key regulator in diseases and a potential target for new treatments.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Leflunomide and anthralin may effectively treat severe alopecia areata.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Baricitinib is an effective treatment for severe alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Pexidartinib often causes liver issues and fatigue, especially in women.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

The rash resolved after stopping ponatinib.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Kūlaris improved quality of life for acne sufferers without side effects.